Experiences from a COVID-19 vaccination center at a tertiary care teaching hospital in Delhi, India: Challenges and solutions

Author:

Sharma PriyankaORCID,Pardeshi Geeta

Abstract

India began its nationwide coronavirus disease 2019 (COVID-19) vaccination program on January 16, 2021, in a phased manner. In this paper, we have discussed our experience at one of the COVID-19 vaccination centers in the country and have identified a few of the major challenges and their implications. The guidelines for COVID-19 vaccination in the country were changing frequently, leading to ambiguity among the beneficiaries. Co-WIN software, used for program implementation, had some glitches, which caused dissatisfaction among the service providers and beneficiaries. Vaccine hesitancy and eagerness caused low vaccine uptake initially and overcrowding at vaccination centers later. Some of the vaccination centers had the potential to become hot spots for further spread of the virus due to insufficient infrastructure. The disparity in access to vaccines for the homeless and other vulnerable groups was another hurdle for adequate vaccination coverage. These challenges could have been addressed by pretesting the information technology platform, long-term planning with a vision for handling vaccine hesitancy and eagerness, strong communication systems, removing disparities in vaccine access, and maintaining uniformity in messages for frequently updating guidelines.

Publisher

Weston Medical Publishing

Reference16 articles.

1. Pandey A, Sah P, Moghadas SM, et al.: Challenges facing COVID-19 vaccination in India: Lessons from the initial vaccine rollout. J Glob Health. 2021; 11: 03083.

2. Choudhary OP, Choudhary P, Singh I: India’s COVID-19 vaccination drive: Key challenges and resolutions. Lancet Infect Dis. 2021; 21: 1483-1484.

3. Rackimuthu S, Hasan MM, Bardhan M, et al.: COVID-19 vaccination strategies and policies in India: The need for further re-evaluation is a pressing priority. Health Plann Manag. 2022; 37: 1847-1850.

4. Vashishtha VM, Kumar P: Responding to new challenges: Is there a need to relook and revise our COVID-19 vaccination strategy? Expert Rev Vaccines. 2022; 21: 1015-1018.

5. Ministry of Health & Family Welfare: Centre writes to states/UTs to increase the interval between two doses of Covishield to 4-8 weeks based on NTAGI and NEGVAC recommendation. Protection enhanced if the second dose of Covishield is administered between 6-8 weeks. Ministry of Health & Family Welfare, Government of India. 2021. Available at https://pib.gov.in/PressReleasePage.aspx?PRID=1706597. Accessed June 24, 2021.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3